In the BioHarmony Drug Report Database
Conivaptan
Vaprisol (conivaptan) is a small molecule pharmaceutical. Conivaptan was first approved as Vaprisol on 2005-12-29. It is used to treat hyponatremia in the USA. The pharmaceutical is active against vasopressin V1a receptor and vasopressin V2 receptor.
Trade Name
|
Vaprisol, Vaprisol In Dextrose |
|---|---|
Common Name
|
conivaptan |
ChEMBL ID
|
CHEMBL1755 |
Indication
|
hyponatremia |
Drug Class
|
Vasopressin receptor antagonists |
Image (chem structure or protein)